Albus Health Secures Funding for Innovative Healthcare Solutions

Albus Health Ltd, a pioneering venture emerging from the University of Oxford, is revolutionising asthma management with its cutting-edge technology. Asthma affects over 150 million individuals globally, costing billions of dollars annually in healthcare expenses. Existing monitoring methods often prove ineffective, with less than 20% adoption rate due to their cumbersome nature.

‍

Addressing this pressing need, Albus Health has developed an innovative automated real-time home monitoring system. This device predicts asthma attacks days in advance, empowering patients to proactively manage their condition and avert potential crises. Unlike traditional methods reliant on manual input, Albus Health's solution collects objective data seamlessly, eliminating the need for active patient involvement.

‍

Founded by Mikesh Udani and William Do, both alumni of the Oxford Biodesign Healthcare Innovations Programme, Albus Health has made significant strides in the healthcare technology landscape. Despite initial challenges, including financial constraints and personnel changes, the steadfast dedication of its founders has propelled the company forward.

‍

Securing funding from reputable sources such as Innovate UK and Oxford-based VC OSI, Albus Health is well-positioned to realize its vision of bridging the gap in clinical monitoring. With a diverse team of over 10 professionals, the company is committed to developing versatile platform technology applicable beyond asthma to various cardio-respiratory conditions.

‍

Driven by innovation, Albus Health has already achieved notable milestones, including the filing of two patents, development of a Minimum Viable Product (MVP), and initiation of clinical trials. Furthermore, the company has inked its first sales contract with a multinational corporation, signifying growing recognition and demand for its groundbreaking solutions.

‍

The success of Albus Health underscores the transformative potential of technology in healthcare. By leveraging advanced analytics and predictive capabilities, the company aims to enhance patient outcomes and reduce healthcare costs associated with chronic conditions like asthma. With a focus on empowering individuals to take control of their health, Albus Health epitomises the spirit of innovation driving progress in modern medicine.

‍

In conclusion, Albus Health's pioneering efforts in asthma management exemplify the convergence of technology and healthcare. With its automated monitoring system, the company offers a proactive approach to managing chronic conditions, heralding a new era in personalized healthcare. As Albus Health continues to advance its technology and expand its reach, it holds the promise of transforming lives and reshaping the future of healthcare delivery.